Presentation TVT 2021 PFO Closure for Stroke: When Should We Consider Patients Over 60 Years of Age? Presenter: Megan Coylewright July 22, 2021
Presentation TVT 2021 When Both Silent AF and PFO Are Discovered During a Cryptogenic Stroke Work-up, the Optimal Therapy to Prevent Stroke Recurrence Is… Presenter: Mark Reisman July 22, 2021
Presentation TVT 2021 Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR Presenter: George Dangas July 21, 2021
Presentation TVT 2021 Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions Presenter: Samir Kapadia July 21, 2021
Presentation TVT 2021 Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR Presenter: Amar Krishnaswamy July 21, 2021
News Conference News TVT 2021 TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year Todd Neale July 20, 2021
News Daily News Predictors of Device-Related Thrombus Following LAA Occlusion Shelley Wood July 19, 2021
News Daily News De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis Yael L. Maxwell July 16, 2021
News Daily News Latest Statin Risk-Benefit Analysis: More Harm Than Good? Yael L. Maxwell July 15, 2021
News Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS Yael L. Maxwell July 13, 2021
News Daily News Athletes Have an Increased Risk of AF, Meta-analysis Confirms Todd Neale July 13, 2021
News Daily News FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes Yael L. Maxwell July 09, 2021